Mammograms cut risk of breast cancer death nearly in half
If a woman's mammogram tests positive for an estrogen-sensitive malignancy, she may find it cost-efficient to buy Canadian Tamoxifen.
If a woman's mammogram tests positive for an estrogen-sensitive malignancy, she may find it cost-efficient to buy Canadian Tamoxifen. These medical screens are one of the most powerful tools in the fight against breast cancer. New research from the Netherlands suggests that undergoing at least three mammograms before a positive diagnosis can reduce the risk of death by 49 percent.
A team of scientists analyzed the records of 755 patients who died from breast cancer, and compared them to more than 3,700 controls. About 30 percent of cancer cases were detected at screening, 34 percent in between mammograms and 36 percent in women who were never tested.
Broken down by age group, subjects aged 70 to 75 years cut their risk of death by 84 percent if they had at least three mammograms. In the 50 to 69 age range, it was 39 percent.
Nearly 30 percent of stage IV tumors were found in patients who never had mammograms, compared to 5 percent in those who had medical imaging, as published in the journal Cancer Epidemiology, Biomarkers & Prevention.
"Our study adds further evidence that mammography screening unambiguously reduces breast cancer mortality," said researcher Suzie Otto, PhD. She believes that this principle can apply to the U.S. as well.
However, what makes the Netherlands different is that there is a centralized government-funded program for mammograms.
|
